Screening compound: C32H38N4O5 (V009-5617)

Screening compound: C<sub>32</sub>H<sub>38</sub>N<sub>4</sub>O<sub>5</sub> (V009-5617)
Screening compound: C<sub>32</sub>H<sub>38</sub>N<sub>4</sub>O<sub>5</sub> (V009-5617) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C32H38N4O5 (V009-5617)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-5617

Molecular Formula

C32H38N4O5 (C32 H38 N4 O5)

Compound Name

N-{1-[4-(3-cyclopentylpropanoyl)-3-methylpiperazin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl}-2H-1,3-benzodioxole-5-carboxamide

IUPAC name

N-{1-[4-(3-cyclopentylpropanoyl)-3-methylpiperazin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl}-2H-13-benzodioxole-5-carboxamide

SMILES

CC(CN(CC1)C(C(Cc2c[nH]c3c2cccc3)NC(c(cc2)cc3c2OCO3)=O)=O)N1C(CCC1CCCC1)=O

InChI

InChI=1S/C32H38N4O5/c1-21-19-35(14-15-36(21)30(37)13-10-22-6-2-3-7-22)32(39)27(16-24-18-33-26-9-5-4-8-25(24)26)34-31(38)23-11-12-28-29(17-23)41-20-40-28/h4-5,8-9,11-12,17-18,21-22,27,33H,2-3,6-7,10,13-16,19-20H2,1H3,(H,34,38)

InChI Key

XNHBJADXXXUUFQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01302610

C32H38N4O5 (V009-5617) in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Indole Derivatives (10091 compounds)

Lipid Metabolism Library (9174 compounds)

PLpro Library (6343 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C32H38N4O5 (V009-5617) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C32H38N4O5 (V009-5617)?
Check Price and Availability of C32H38N4O5 (V009-5617), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C32H38N4O5 (V009-5617) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C32H38N4O5 (V009-5617)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C32H38N4O5 (V009-5617)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C32H38N4O5 (V009-5617) available by request